Revenue,
USD 726.42 Bn
Forecast Year,
USD 1,738.73 Bn
CAGR, 2025 -
9.12%
Report Coverage
Worldwide
Drug and Gene Delivery Devices Market Size Analysis
Drug and Gene Delivery Devices Market Size By Vector-Type 2024 to 2034 (USD )
| Vector-Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Viral Vector | 450.38 | 491.60 | 536.58 | 585.69 | 639.28 | 697.78 | 761.64 | 831.34 | 907.41 | 990.45 | 1081.08 |
| Non-viral Vector | 174.34 | 190.77 | 208.73 | 228.40 | 249.91 | 273.44 | 299.19 | 327.36 | 358.17 | 391.89 | 428.78 |
| Physical/Device-based | 101.70 | 110.31 | 119.64 | 129.76 | 140.74 | 152.63 | 165.52 | 179.50 | 194.65 | 211.07 | 228.87 |
Drug and Gene Delivery Devices Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Injectable | 392.27 | 428.69 | 468.50 | 512.00 | 559.55 | 611.51 | 668.30 | 730.37 | 798.20 | 872.33 | 953.36 |
| Oral | 116.23 | 126.24 | 137.11 | 148.92 | 161.73 | 175.64 | 190.73 | 207.12 | 224.90 | 244.20 | 265.14 |
| Inhalation | 87.17 | 94.02 | 101.40 | 109.33 | 117.86 | 127.03 | 136.89 | 147.48 | 158.86 | 171.08 | 184.19 |
| Transdermal/Others | 130.76 | 143.71 | 157.95 | 173.60 | 190.79 | 209.68 | 230.43 | 253.23 | 278.28 | 305.80 | 336.03 |
Drug and Gene Delivery Devices Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 334.15 | 364.51 | 397.63 | 433.75 | 473.16 | 516.15 | 563.04 | 614.20 | 670.01 | 730.88 | 797.29 |
| Research/Academic | 246.98 | 270.21 | 295.61 | 323.40 | 353.79 | 387.03 | 423.38 | 463.14 | 506.63 | 554.18 | 606.20 |
| Homecare/Other | 145.28 | 157.95 | 171.72 | 186.70 | 202.98 | 220.68 | 239.92 | 260.85 | 283.60 | 308.34 | 335.24 |
Drug and Gene Delivery Devices Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 261.51 | 285.41 | 311.49 | 339.95 | 371.02 | 404.93 | 441.93 | 482.32 | 526.40 | 574.51 | 627.01 |
| Europe | 203.40 | 221.53 | 241.26 | 262.76 | 286.15 | 311.63 | 339.37 | 369.56 | 402.44 | 438.23 | 477.18 |
| Asia Pacific | 210.66 | 229.54 | 250.11 | 272.52 | 296.93 | 323.52 | 352.48 | 384.04 | 418.41 | 455.84 | 496.62 |
| Latin America | 29.06 | 33.45 | 38.43 | 44.05 | 50.40 | 57.56 | 65.64 | 74.75 | 85.00 | 96.54 | 109.51 |
| Middle East & Africa | 21.79 | 22.74 | 23.67 | 24.57 | 25.43 | 26.22 | 26.92 | 27.53 | 27.99 | 28.30 | 28.40 |
Drug and Gene Delivery Devices Market
Drug and Gene Delivery Devices Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com